Skip to main content

Author: Customer Service

Biofrontera Inc. to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call on March 19, 2026

WOBURN, Mass., March 09, 2026 (GLOBE NEWSWIRE) — Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT), announces it will report financial results for the three months and full year ended December 31, 2025 after the close of the U.S. financial markets on Thursday, March 19, 2026. The Company will host a conference call on Thursday, March 19, 2026 at 10:00 a.m. Eastern Time to discuss those results, provide a business update and answer questions. Conference Call and Webcast InformationEvent: Biofrontera Inc. Fourth Quarter and Full Year 2025 Financial Results and Business Update Conference CallDate: Thursday, March 19, 2026Time: 10:00 a.m. ETConference Call: 1-888-222-5806 (U.S.)1-412-902-6516 (international)Webcast: Webcast...

Continue reading

Flagship Communities Real Estate Investment Trust Announces Fourth Quarter and Full Year 2025 Results

Not for distribution to U.S. newswire services or dissemination in the United States. TORONTO, March 09, 2026 (GLOBE NEWSWIRE) — Flagship Communities Real Estate Investment Trust (“Flagship” or the “REIT”) (TSX: MHC.U; MHC.UN) today released its fourth quarter and full year 2025 results. The financial results of the REIT have been prepared in accordance with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”). Results are shown in U.S. dollars, unless otherwise noted. Fourth Quarter 2025 ResultsCompared to Fourth Quarter 2024 ResultsRental revenue and related income was $27.5 million, an increase of 15.6% compared to $23.8 million Same Community Revenue1 was $23.2 million, up 8.2% compared to $21.4 million Net income and comprehensive income was $45.5 million...

Continue reading

CPS to Host Conference Call on Fourth Quarter 2025 Earnings

LAS VEGAS, Nevada, March 09, 2026 (GLOBE NEWSWIRE) — Consumer Portfolio Services, Inc. (Nasdaq: CPSS) (“CPS” or the “Company”) today announced that it will hold a conference call on Wednesday, March 11, 2026 at 1:00 p.m. ET to discuss its fourth quarter 2025 operating results. Those wishing to participate can pre-register for the conference call at the following link https://register-conf.media-server.com/register/BI939b54a85b184d6b8c4cb82440102b17. Registered participants will receive an email containing conference call details for dial-in options. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the schedule start time. A replay will be available beginning two hours after conclusion of the call for 12 months via the Company’s website at https://ir.consumerportfolio.com/investor-relations. About...

Continue reading

SAB BIO Reports Full Year 2025 Financial Results and Business Highlights

Advanced SAB -142 into registrational Phase 2b SAFEGUARD study with multiple patients dosed; enrollment ongoing and on track to complete enrollment by end of 2026 with topline data expected in 2H 2027 Reported Phase 1 clinical data, including healthy volunteer, redosing, and T1D cohorts supporting SAB-142’s favorable safety profile, redosability, and continued clinical development Raised $175 million in an oversubscribed private placement with leading institutional and strategic investors to fully fund SAFEGUARD Strong cash position with operational runway through 2028 MIAMI, March 09, 2026 (GLOBE NEWSWIRE) — SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other autoimmune diseases, today announced financial...

Continue reading

Alaris Releases 2025 Fourth Quarter Financial Results

Not for Distribution in the United States. Failure to Comply With This Restriction May Constitute a Violation of United States Securities Law. CALGARY, Alberta, March 09, 2026 (GLOBE NEWSWIRE) — Alaris Equity Partners Income Trust (together, as applicable, with its subsidiaries, “Alaris” or the “Trust“) is pleased to announce its results for the three months and year ended December 31, 2025. The results are prepared in accordance with IFRS Accounting Standards as issued by the International Accounting Standards Board. All amounts below are in Canadian dollars unless otherwise noted. HighlightsStrong Operating Growth: Total revenue and operating income increased 15.9% in Q4 and 14.0% for the year, driven primarily by a $73.2 million net unrealized gain on Partner investments (2024 – $47.3 million). Earnings from operations...

Continue reading

MAX Power Adopts Shareholder Rights Plan

MAX Power Saskatchewan Natural Hydrogen Documentary Videohttps://www.maxpowermining.com/NaturalHydrogen-NewEra/ SASKATOON, Saskatchewan, March 09, 2026 (GLOBE NEWSWIRE) — MAX Power Mining Corp. (CSE: MAXX; OTC: MAXXF; FSE: 89N) (“MAX Power” or the “Company”) announces that the Board of Directors of the Company has adopted a Shareholder Rights Plan and has entered into a Shareholder Rights Plan Agreement with TMX Trust Company as Rights Agent effective today. The Shareholder Rights Plan is consistent with rights plans adopted by other Canadian public companies and has not been adopted in response to any specific proposal or intention to acquire control of MAX Power. In the event of an unsolicited takeover bid in the future, the purpose of the Shareholder Rights Plan is to provide the Board and shareholders of MAX Power with an adequate...

Continue reading

Relmada Therapeutics to Present at the Leerink Partners Global Healthcare Conference

CORAL GABLES, Fla., March 09, 2026 (GLOBE NEWSWIRE) — Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for oncology and central nervous system disorders, today announced that Sergio Traversa, Chief Executive Officer, and Maged Shenouda, Chief Financial Officer, will participate in the Leerink Partners Global Healthcare Conference being held in Miami, Florida, from March 8-11, 2026. Leerink Partners Global Healthcare Conference DetailsFormat: Fireside ChatDate Tuesday, March 10, 2026Time: 8:40 AM ETWebcast: Click Here Management will also be available for one-one-one investor meetings during the conference. Please contact your Leerink Partners representative to schedule a meeting. The webcast can also be accessed on the Events page the Investors...

Continue reading

Mesa Laboratories Announces CEO Transition and Appointment of Siddhartha Kadia as President and CEO

LAKEWOOD, Colo., March 09, 2026 (GLOBE NEWSWIRE) —  Mesa Laboratories, Inc. (NASDAQ: MLAB) (“Mesa” or “the Company”), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced that Gary Owens will step down as President and CEO on April 12, 2026, and will enable a smooth leadership transition. “Gary has served as Mesa’s CEO since 2017, leading Mesa through a period of significant growth, expansion into new markets, the maturation of the company’s foundation, and the implementation of The Mesa Way business system,” said John Sullivan, Chair of the Board. “We are grateful for his leadership and wish him continued success.” To lead the Company’s next chapter, the Board of Directors has appointed Dr. Siddhartha Kadia as President and Chief Executive Officer, effective...

Continue reading

Xos Announces Production Rollout of Vehicle-to-Grid Capability Across Its Full Commercial Electric Vehicle and Energy Solutions Portfolio

V2G Is Here — Xos Enters ProductionThe connection that changes everything. V2G production begins April 2026.V2G production scheduled for April 2026 on one of North America’s largest school bus platforms, enabling fleets to return energy to the grid and offset operating costs Bidirectional technology roadmap will extend across Xos’s product portfolioLOS ANGELES, March 09, 2026 (GLOBE NEWSWIRE) — Xos, Inc. (NASDAQ: XOS) (“Xos” or the “Company”), a leader in electric commercial vehicles and mobile charging solutions, today announced V2G (Vehicle-to-Grid) production beginning in April 2026 on a major electric school bus platform in North America, with a clear roadmap to extend bidirectional capability across its product portfolio, including step vans, powertrains, and energy storage solutions. Building on its track record...

Continue reading

Cal-Maine Foods Schedules Third Quarter Fiscal 2026 Earnings Release, Conference Call and Webcast

RIDGELAND, Miss., March 09, 2026 (GLOBE NEWSWIRE) — Cal-Maine Foods, Inc. (NASDAQ: CALM), the largest egg company in the United States and a leading player in the egg-based prepared food industry, today announced it will report results for its fiscal 2026 third quarter at approximately 6:00 a.m. ET on Wednesday, April 1, 2026. The earnings release will be available on the Cal-Maine Foods website at https://www.calmainefoods.com/press-releases. Management will review the results during a conference call and webcast at 9:00 a.m. ET the same day. Participants can access the live webcast on the Investor Relations page of the Cal-Maine Foods website at https://www.calmainefoods.com/events-presentations. To join by telephone, participants can register in advance here. Upon registering, participants will receive the dial-in info and a...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.